Winton Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.69M | Sell |
137,553
-11,402
| -8% | -$140K | 0.09% | 279 |
|
2025
Q1 | $3.28M | Buy |
+148,955
| New | +$3.28M | 0.2% | 124 |
|
2022
Q4 | – | Sell |
-9,971
| Closed | -$422K | – | 978 |
|
2022
Q3 | $422K | Buy |
9,971
+5,250
| +111% | +$222K | 0.03% | 689 |
|
2022
Q2 | $255K | Buy |
+4,721
| New | +$255K | 0.01% | 841 |
|
2021
Q1 | – | Sell |
-9,142
| Closed | -$593K | – | 1405 |
|
2020
Q4 | $593K | Buy |
9,142
+2,029
| +29% | +$132K | 0.04% | 699 |
|
2020
Q3 | $336K | Buy |
+7,113
| New | +$336K | 0.01% | 1212 |
|
2018
Q3 | – | Sell |
-180,258
| Closed | -$11.6M | – | 1055 |
|
2018
Q2 | $11.6M | Buy |
180,258
+162,907
| +939% | +$10.5M | 0.3% | 93 |
|
2018
Q1 | $960K | Buy |
+17,351
| New | +$960K | 0.03% | 517 |
|
2017
Q2 | – | Sell |
-13,654
| Closed | -$575K | – | 614 |
|
2017
Q1 | $575K | Buy |
13,654
+4,822
| +55% | +$203K | 0.02% | 364 |
|
2016
Q4 | $379K | Buy |
+8,832
| New | +$379K | 0.01% | 391 |
|